186 related articles for article (PubMed ID: 23226476)
1. Transgenesis-mediated reproductive dysfunction and tumorigenesis: effects of immunological neutralization.
Sachdeva R; Bhardwaj N; Huhtaniemi I; Aggrawal U; Jain SK; Zaidi R; Singh O; Pal R
PLoS One; 2012; 7(11):e51125. PubMed ID: 23226476
[TBL] [Abstract][Full Text] [Related]
2. Synergistic activation of innate and adaptive immune mechanisms in the treatment of gonadotropin-sensitive tumors.
Bose A; Huhtaniemi I; Singh O; Pal R
PLoS One; 2013; 8(4):e61288. PubMed ID: 23593454
[TBL] [Abstract][Full Text] [Related]
3. The permissive role of prolactin as a regulator of luteinizing hormone action in the female mouse ovary and extragonadal tumorigenesis.
Bachelot A; Carré N; Mialon O; Matelot M; Servel N; Monget P; Ahtiainen P; Huhtaniemi I; Binart N
Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E845-52. PubMed ID: 23921141
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin and tumorigenesis: Direct and indirect effects on inflammatory and immunosuppressive mediators and invasion.
Khare P; Bose A; Singh P; Singh S; Javed S; Jain SK; Singh O; Pal R
Mol Carcinog; 2017 Feb; 56(2):359-370. PubMed ID: 27152491
[TBL] [Abstract][Full Text] [Related]
5. The pleiotropic effects of excessive luteinizing hormone secretion in transgenic mice.
Sutton AL; Keri RA
Semin Reprod Med; 2007 Sep; 25(5):360-7. PubMed ID: 17710732
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of human chorionic gonadotropin causes multiple reproductive defects in transgenic mice.
Matzuk MM; DeMayo FJ; Hadsell LA; Kumar TR
Biol Reprod; 2003 Jul; 69(1):338-46. PubMed ID: 12672665
[TBL] [Abstract][Full Text] [Related]
7. The transgenic expression of the β-subunit of human chorionic gonadotropin influences the growth of implanted tumor cells.
Singh P; Sarkar M; Agrawal U; Huhtaniemi I; Pal R
Oncotarget; 2018 Oct; 9(78):34670-34680. PubMed ID: 30410667
[TBL] [Abstract][Full Text] [Related]
8. Effects of human chorionic gonadotropin (hCG) and prolactin (PRL) on 3 beta-hydroxy-5-ene-steroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD) expression and activity in the rat ovary.
Martel C; Labrie C; Couët J; Dupont E; Trudel C; Luu-The V; Takahashi M; Pelletier G; Labrie F
Mol Cell Endocrinol; 1990 Aug; 72(2):R7-13. PubMed ID: 2149342
[TBL] [Abstract][Full Text] [Related]
9. Genetically modified mouse models addressing gonadotropin function.
Ratner LD; Rulli SB; Huhtaniemi IT
Reprod Biol; 2014 Mar; 14(1):9-15. PubMed ID: 24607250
[TBL] [Abstract][Full Text] [Related]
10. Vaccines for control of fertility and hormone dependent cancers.
Talwar GP; Singh O; Pal R; Chatterjee N
Int J Immunopharmacol; 1992 Apr; 14(3):511-4. PubMed ID: 1618603
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of endocrine parameters in clinical trials with beta-hCG vaccine.
Shahani S; Patel KL; Merchant P
Contraception; 1991 Jan; 43(1):67-75. PubMed ID: 1706244
[TBL] [Abstract][Full Text] [Related]
12. Expression of ovarian prolactin receptor in relation to hormonal changes during induction of ovulation in the rat.
Kinoshita H; Yasui T; Ushigoe K; Irahara M; Tanaka M; Nakashima K; Aono T
Gynecol Obstet Invest; 2001; 52(2):132-8. PubMed ID: 11586043
[TBL] [Abstract][Full Text] [Related]
13. Gonadotropin-mediated chemoresistance: Delineation of molecular pathways and targets.
Sahoo S; Singh P; Kalha B; Singh O; Pal R
BMC Cancer; 2015 Nov; 15():931. PubMed ID: 26608647
[TBL] [Abstract][Full Text] [Related]
14. Immunological approaches against human chorionic gonadotropin for control of fertility and therapy of advanced-stage cancers expressing hCG/subunits.
Talwar GP; Gupta JC; Shankar NV
Am J Reprod Immunol; 2011 Jul; 66(1):26-39. PubMed ID: 21501278
[TBL] [Abstract][Full Text] [Related]
15. Antibody response against epitopes on hCG mapped by monoclonal antibodies in women immunized with an anti-hCG vaccine and its implications for bioneutralization.
Deshmukh US; Pal R; Talwar GP; Gupta SK
J Reprod Immunol; 1993 Nov; 25(2):103-17. PubMed ID: 7513023
[TBL] [Abstract][Full Text] [Related]
16. Reproductive disturbances, pituitary lactotrope adenomas, and mammary gland tumors in transgenic female mice producing high levels of human chorionic gonadotropin.
Rulli SB; Kuorelahti A; Karaer O; Pelliniemi LJ; Poutanen M; Huhtaniemi I
Endocrinology; 2002 Oct; 143(10):4084-95. PubMed ID: 12239120
[TBL] [Abstract][Full Text] [Related]
17. Immunological cross-reactivity of antibodies with species chorionic gonadotropin is a critical requirement for efficacy testing of human gonadotropin vaccines in sub-human primates.
Rao LV; Singh O; Talwar GP
J Reprod Immunol; 1988 Jun; 13(1):53-63. PubMed ID: 3418617
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of antigonadotropin response to the beta-subunit of ovine luteinizing hormone by carrier conjugation and combination with the beta-subunit of human chorionic gonadotropin.
Talwar GP; Singh O; Singh V; Rao DN; Sharma NC; Das C; Rao LV
Fertil Steril; 1986 Jul; 46(1):120-6. PubMed ID: 2424791
[TBL] [Abstract][Full Text] [Related]
19. Anti-LHRH and anti-pituitary gonadotropin vaccines: their development and clinical applications.
Thau R
Scand J Immunol Suppl; 1992; 11():127-30. PubMed ID: 1514027
[TBL] [Abstract][Full Text] [Related]
20. Bioneutralization capacity of the antibodies generated in women by the beta subunit of human chorionic gonadotropin (beta hCG) and beta hCG associated with the alpha subunit of ovine luteinizing hormone linked to carriers.
Pal R; Singh O; Rao LV; Talwar GP
Am J Reprod Immunol; 1990; 22(3-4):124-6. PubMed ID: 1695850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
